TORNADO
Cambrian BioPharma, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97978188 |
| Mark Drawing Code | 4: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Carl Eppler |
| Attorney Docket Number | 0735790 |
| Law Office Assigned | N40 |
| Employee Name | SALES, HEATHER ALISON |
Timeline
| 2022-02-16 | Date of First Use |
| 2022-03-21 | Application Filed |
| 2023-04-18 | Published for Opposition |
| 2024-05-08 | Location: TMO LAW OFFICE 122 |
| 2024-05-08 | Status: Live/Pending |
| 2024-05-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Cambrian BioPharma, Inc. |
| Address | #66643 228 Park Ave. South New York DE 10003 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Scientific and technological services, namely, pharmaceutical research and design services relating thereto in the nature of pharmaceutical development; pharmaceutical development services; scientific research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; pharmaceutical testing, pre-clinical research, and clinical research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; medical research; provision of information and consultancy relating to medical and scientific research in the fields of clinical trials, oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, and the mTOR pathway |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2022-03-24 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2022-03-25 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2023-01-04 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-01-09 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2023-01-09 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-01-09 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-03-02 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-03-02 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-03-02 | 9 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2023-03-09 | 10 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2023-03-09 | 11 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-03-09 | 12 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2023-03-09 | 13 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-03-11 | 14 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-03-29 | 15 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2023-04-18 | 16 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-04-18 | 17 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2023-06-13 | 18 NOAM E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-11-29 | 19 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-11-29 | 20 CHAN I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-11-29 | 21 TCCA I:Incoming Correspondence |
| SOU TEAS EXTENSION RECEIVED | 2023-12-12 | 22 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2023-12-12 | 23 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2023-12-12 | 24 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-12-14 | 25 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2024-04-08 | 26 EISU I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2024-04-08 | 27 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2024-04-29 | 28 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2024-04-08 | 29 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2024-05-08 | 30 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2024-04-08 | 31 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2024-05-08 | 32 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2024-05-14 | 33 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2024-05-14 | 34 SUNA E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 